Based on 2 analysts offering 12 month price targets for Biodesix Inc
Min Forecast
$3.00+191.26%
Avg Forecast
$3.00+191.26%
Max Forecast
$3.00+191.26%
Should I buy or sell BDSX stock?
Based on 2 analysts offering ratings for Biodesix Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BDSX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BDSX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their BDSX stock forecasts and price targets.
Is Biodesix Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: BDSX) stock is to Buy BDSX stock.
Out of 2 analysts, 0 (0%) are recommending BDSX as a Strong Buy, 2 (100%) are recommending BDSX as a Buy, 0 (0%) are recommending BDSX as a Hold, 0 (0%) are recommending BDSX as a Sell, and 0 (0%) are recommending BDSX as a Strong Sell.
What is BDSX's earnings growth forecast for 2025-2025?
(NASDAQ: BDSX) Biodesix's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Biodesix's earnings in 2025 is -$43,819,000.
In 2025, BDSX is forecast to generate -$34,912,151 in earnings, with the lowest earnings forecast at -$34,912,151 and the highest earnings forecast at -$34,912,151.
What is BDSX's revenue growth forecast for 2025-2025?
(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Biodesix's revenue in 2025 is $65,562,000.
In 2025, BDSX is forecast to generate $13,259,343,939 in revenue, with the lowest revenue forecast at $13,062,963,091 and the highest revenue forecast at $13,455,724,788.
What is BDSX's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: BDSX) forecast ROA is -33.98%, which is lower than the forecast US Diagnostics & Research industry average of 9.14%.
What is BDSX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year BDSX price target, the average BDSX price target is $3.00, with the highest BDSX stock price forecast at $3.00 and the lowest BDSX stock price forecast at $3.00.
On average, Wall Street analysts predict that Biodesix's share price could reach $3.00 by Sep 16, 2025. The average Biodesix stock price prediction forecasts a potential upside of 191.26% from the current BDSX share price of $1.03.
What is BDSX's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: BDSX) Biodesix's current Earnings Per Share (EPS) is -$0.38. In 2025, BDSX's EPS is forecast to hit -$0.24 (min: -$0.24, max: -$0.24).
What is BDSX's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: BDSX) forecast ROE is -125.33%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.